Inhibition of fatty acid oxidation with pent-4-enoate in suckling newborn rats caused a fall in blood [glucose] and blood [ketone bodies] and inhibition of gluconeogenesis from lactate. Glucose utilization was not increased in newborn rats injected with pent-4-enoate. Active fatty acid oxidation appears to be essential to support gluconeogenesis and to maintain normal blood [glucose] in suckling newborn rats.
Inhibition of fatty acid oxidation with pent-4-enoate in suckling newborn rats caused a fall in blood [glucose] and blood [ketone bodies] and inhibition of gluconeogenesis from lactate. Glucose utilization was not increased in newborn rats injected with pent-4-enoate. Active fatty acid oxidation appears to be essential to support gluconeogenesis and to maintain normal blood [glucose] in suckling newborn rats.
A profound hypoglycaemia develops in starved newborn rats (Haymond et al., 1972; Wapnir et al., 1973; Girard et al., 1973 Girard et al., , 1975 , secondary to a deficiency of gluconeogenesis (Girard et al., 1975) . It has been suggested that gluconeogenesis may be limited during starvation by unavailability of gluconeogenic substrates (Haymond et al., 1972; Girard etal., 1975) andnon-esterifiedfatty acids (Girard et al., 1975) . Starvation-induced hypoglycaemia is partially reversed by fat feeding, and is completely reversed by fat feeding in combination with injection of gluconeogenic substrates (Ferr6 et al., 1977b) . Suckling newborn rats maintain their blood [glucose] mainly by gluconeogenesis (Snell & Walker, 1973; Ferre et al., 1977a) . They obtain their non-esterified fatty acids from the milk, which is a high-fat low-carbohydrate diet (Luckey et al., 1954) . PentA-enoate inhibits fatty acid oxidation and produces hypoglycaemia when administered to food-deprived adult mice and rats (Corredor et al., 1967; Senior & Sherratt, 1969) . On the basis of studies in vitro, the hypoglycaemic effect of pent-4-enoate has been attributed to inhibition ofgluconeogenesis, secondary to impairment of fatty acid oxidation (Ruderman et al., 1970; Williamson et al., 1970) . In the present study, pent-4-enoate was used to investigate the effects of inhibition of fatty acid oxidation on glucose homoeostasis in suckling newborn rats.
Experimental Animals
Rat pups of an albino Wistar strain were born between 15: 00 and 18: OOh on day 22 of gestation. They were left with the mother for 16h after delivery in a room in which external temperature was 22°C. The pups began to suckle between 1 and 2h after birth.
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Experimental design
Each litter of 16h-old rats was divided into two groups. One was injected subcutaneously with sodium pent-4-enoate (pH7.4) at a dose of 2mg/g body wt. and the other was injected with the same volume (50u1) of 0.9% NaCl. The pups were then immediately placed in a Humidicrib (Jouan S.A., Paris, France) in which the temperature was maintained at 37°C and the relative humidity at 70 %.
In the experiments in which blood metabolites and hormones were determined, the newborn rats were killed 2.5h after injections of pent-4-enoate or NaCl. The maximum effects of pent-4-enoate were observed at this time.
In the gluconeogenesis studies, the newborn rats were injected intraperitoneally with labelled precursor (luCi of [U-"4C]lactate or l,cCi of [U-"C]-glycerol) 2h after pent-4-enoate or NaCl injections, placed again in the Humidicrib and killed 30min after injection of the labelled precursor.
In the glucose-tolerance studies, the newborn rats were injected intraperitoneally with D-glucose (2mg/g body wt.) 30min after pent-4-enoate or NaCl injections, placed again in the Humidicrib and killed 30, 60, 120 or 180 min after injection of glucose.
Blood samples for metabolite and hormone assays were collected as described previously (Girard et al., 1973 (Girard et al., , 1975 .
Measurement of gluconeogenesis rates in vivo from 4C-labelled substrates
The technique used and the method for calculation of rate of gluconeogenesis in vivo were as described previously (Girard et al., 1975 (Girard et al., , 1976 Ferre et al., 1977a) ; lactate and glycerol spaces equal to the total body water were used, i.e. 80mI/lOOg body wt., and a glucose space equal to extracellular body water was used, i.e. 60ml/lOOg body wt. The separation of labelled glucose, lactate and charged compounds was performed by ion-exchange chromatography (Kreisberg et al., 1972) . Labelled glucose was separated from labelled glycerol as described by Pilkis et al. (1976) (Girard et al., 1973) . Plasma non-esterified fatty acids were measured by the radioactive nickel method of Ho (1970) .
Hormones
Plasma insulin and glucagon were determined by radioimmunoassay as previously described (Girard et al., 1973 (Girard et al., , 1975 . Glucagon was assayed by using 30K antiserum (Faloona & Unger, 1974) , which is considered to be specific for pancreatic glucagon.
Statistics
Results are expressed as means ±S.E.M.; significant differences were determined by using the Wilcoxon rank-order test (Wilcoxon, 1947 
Rate ofgluconeogenesis in vivo
The rate of conversion of ['4C]lactate into glucose decreased from 11±1 pmol/h per 100 g body wt. in NaCl-injected newborn rats (n = 6) to 1.8±0.1,umol/ h per lOOg body wt. in newborn rats injected with pent-4-enoate (n = 6) (P<0.01). There was no significant difference in the rate of conversion of [14C] glycerol into glucose between the NaCI-injected newborn animals [3.5,umol/h per 100 g body wt.
(n = 6)] and the newborn rats injected with pent-4-enoate [4.4±0.74umol/h per 100 g body wt. (n = 6)].
Glucose-tolerance test
In order to estimate whether glucose utilization was altered by pent-4-enoate, intraperitoneal glucose tolerance was tested. The results are shown in Fig. 1 . A significant decrease in blood [glucose] (P< 0.01) was already observed 30min after pent-4-enoate injection, before the glucose-tolerance test was started. Although the peak in glycaemia was higher in NaCl-injected newborn rats, the disappearance rate was identical, and blood [glucose] returned to initial values 3 h after glucose injection.
The rate of glucose disappearance calculated from the slope of the semi-logarithmic plot of blood glucose expressed as %/min was 0.54 in NaCl-1977 RAPID PAPERS Plasma insulin and glucagon Plasma insulin decreased from 18+±1 u-i.u./ml in NaCI-injected controls to 10±1 ,u-i.u./ml (P< 0.01), in association with hypoglycaemia, in the newborn rat injected with pent-4-enoate. A significant increase in plasma glucagon was also observed: 906+43 pg/ ml for the NaCl-injected controls versus 1907+ 189pg/mI for the newborn rats injected with pent-4-enoate (P< 0.01). Each value was the ftean of six determinations.
Discussion
In the present study, pent-4-enoate was used to examine the metabolic effects of a blockage of fatty acid oxidation in suckling newborn rats. This compound has been reported to inhibit in vitro the oxidation of long-chain fatty acids in several tissues, particularly the liver [see Sherratt & Osmundsen (1976) for a review]. In vivo, pent-4-enoate raised the plasma [non-esterified fatty acid] and caused marked ketosis in starved rats (Senior & Sherratt, 1969) . In suckling newborn rats, pent-4-enoate produced a fall in blood [ketone bodies] and a rise in plasma [non-esterified fatty acid], which suggests inhibition of fatty acid oxidation. In adult rats, ketosis has been Vol. 166 attributed to greater inhibition of the peripheral utilization of ketone bodies than their production by the liver. The decrease in the rate of ketone-body utilization could be secondary to hypothermia produced by pent-4-enoate injection into adult rat maintained at an environmental temperature less than 26°C (Marley & Sherratt, 1973 (Girard et al., 1975; Ferre et al., 1977a) . Glycerol did not appear to make a major contribution to bloodglucose regulation in suckling newborn rats, since hypoglycaemia occurred even though pent-4-enoate did not inhibit gluconeogenesis from glycerol. Moreover, the fall in blood [glycerol] after pent-4-enoate injection suggests increased utilization of glycerol for gluconeogenesis. This can explain why the rate of gluconeogenesis from glycerol is not decreased by pent-4-enoate despite the 2-fold decrease in glycerol-pool size. The absence of a rise in blood [alanine] when gluconeogenesis was inhibited suggests again that alanine is not a quantitatively important substrate for gluconeogenesis in suckling newborn rats (see also Ferre et al., 1977a) .
Plasma insulin decreased and plasma glucagon increased during pent4-enoate-induced hypoglycaemia. Hypoglycaemia of the same magnitude was observed after inhibition of gluconeogenesis by 3-mercaptopicolinate and was associated with a decrease in plasma [insulin] but no change in plasma [glucagon] (Ferre et al., 1977a) . In vitro, ketone bodies have been shown to inhibit glucagon release from neonatal rat pancreas . In the present studies, the dramatic fall in blood [ketone bodies] induced by pent-4-enoate might have contributed to the increase in plasma [glucagon] .
